We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
246 hedge funds and large institutions have $2.26B invested in Corcept Therapeutics in 2023 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 81 increasing their positions, 92 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 16
76% more call options, than puts
Call options by funds: $11.5M | Put options by funds: $6.54M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
25% more capital invested
Capital invested by funds: $1.81B → $2.26B (+$450M)
9% more funds holding
Funds holding: 225 → 246 (+21)
0.16% more ownership
Funds ownership: 80.25% → 80.41% (+0.16%)
12% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 92
Holders
246
Holders Change
+21
Holders Change %
+9.33%
% of All Funds
3.9%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
40
Increased
81
Reduced
92
Closed
16
Calls
$11.5M
Puts
$6.54M
Net Calls
+$4.99M
Net Calls Change
+$4.39M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$23.8M |
| 2 |
Cerity Partners
New York
|
+$14.8M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$11.5M |
| 4 |
D.E. Shaw & Co
New York
|
+$10.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$10M |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$30.9M |
| 2 |
Man Group
London,
United Kingdom
|
-$17.8M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$6.22M |
| 4 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$4.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$4.88M |
